AJP - Renal Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol (December 26, 2006). doi:10.1152/ajprenal.00164.2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/4/F1238    most recent
00164.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sánchez-Lozada, L. G.
Right arrow Articles by Franco, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sánchez-Lozada, L. G.
Right arrow Articles by Franco, M.
Submitted on June 12, 2006
Accepted on December 18, 2006

Effects of acute and chronic L-arginine treatment in experimental hyperuricemia

Laura G. Sánchez-Lozada1*, Edilia Tapia1, Rubén López-Molina2, Tomás Nepomuceno1, Virgilia Soto3, Carmen Ávila-Casado4, Takahiko Nakagawa5, Richard J. Johnson5, Jaime Herrera-Acosta4, and Martha Franco1

1 Nephrology, INC Ignacio Chavez, Mexico City, Mexico
2 Nephrology, INC Ignacio Chávez, Mexico City, D.F., Mexico
3 Pathology, INC Ignacio Chavez, Mexico City, D.F., Mexico
4 Mexico City, DF, Mexico; Nephrology, INC Ignacio Chavez, Mexico City, Mexico
5 Nephrology, Hypertension and Transplantation, University of Florida, Gainesville, Florida, United States

* To whom correspondence should be addressed. E-mail: lgsanchezlozada{at}hotmail.com.

Experimental hyperuricemia (HU) results in preglomerular arteriolopathy, cortical vasoconstriction and glomerular hypertension. Recently uric acid has been shown to induce endothelial dysfunction. We therefore studied the effect of acute and chronic administration of L-arginine (substrate for endothelial nitric oxide synthase) on the renal hemodynamic and vascular structural alterations induced by HU. To induce HU, oxonic acid (OA, 750 mg/kg/day), was administered in male Sprague-Dawley rats.. To study the acute effect of arginine, 9 rats received L-arginine (L-Arg, 15 mg/kg/min) during micropuncture. To elucidate the chronic effect of L-Arg, OA+ 1% L-Arg (n=8) and OA+ 2.5% L-Arg (n=6) (drinking water) were evaluated throughout the 5 week period. Eight normal control (N),and 8 OA, rats were also studied. Kidneys were fixed by perfusion and afferent arteriole morphology was evaluated. HU rats developed the renal functional and structural alterations described and had suppressed urinary excretion of NO-2/NO-3. Acute stimulation of NO synthesis markedly increased urinary NO-2/NO-3, lowered systemic blood pressure and relieved cortical vasoconstriction despite a significant increment of glomerular hypertension and afferent arteriole damage. Increasing doses of chronic L-Arg were associated with increasing excretion of urinary NO-2/NO-3, reduction of systemic hypertension and prevention of cortical vasoconstriction (2.5% L-Arg). In addition, both doses prevented glomerular hypertension and preglomerular arteriolopathy. Thus an acute relief of renal vasoconstriction in the setting of afferent arteriole damage cannot reverse glomerular hypertension, likely due to impairment in preglomerular autoregulation. On the other hand chronic L-Arg preserved arteriolar structures probably mediated by the antiproliferative effect of NO on VSMC.




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
M. Shimada, R. J. Johnson, W. S. May Jr, V. Lingegowda, P. Sood, T. Nakagawa, Q. C. Van, B. Dass, and A. A. Ejaz
A novel role for uric acid in acute kidney injury associated with tumour lysis syndrome
Nephrol. Dial. Transplant., October 1, 2009; 24(10): 2960 - 2964.
[Full Text] [PDF]


Home page
NEJMHome page
D. I. Feig, D.-H. Kang, and R. J. Johnson
Uric Acid and Cardiovascular Risk
N. Engl. J. Med., October 23, 2008; 359(17): 1811 - 1821.
[Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
L. G. Sanchez-Lozada, V. Soto, E. Tapia, C. Avila-Casado, Y. Y. Sautin, T. Nakagawa, M. Franco, B. Rodriguez-Iturbe, and R. J. Johnson
Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia
Am J Physiol Renal Physiol, October 1, 2008; 295(4): F1134 - F1141.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
D. I. Feig, B. Soletsky, and R. J. Johnson
Effect of Allopurinol on Blood Pressure of Adolescents With Newly Diagnosed Essential Hypertension: A Randomized Trial
JAMA, August 27, 2008; 300(8): 924 - 932.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
L. G. Sanchez-Lozada, E. Tapia, P. Bautista-Garcia, V. Soto, C. Avila-Casado, I. P. Vega-Campos, T. Nakagawa, L. Zhao, M. Franco, and R. J. Johnson
Effects of febuxostat on metabolic and renal alterations in rats with fructose-induced metabolic syndrome
Am J Physiol Renal Physiol, April 1, 2008; 294(4): F710 - F718.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.